Apr 08–11, 2024 | Herrenhausen Palace, Hannover, Germany
Scientific Organizers:
Melanie M. Ott, Priti Kumar, Olivier Schwartz, and Alex Sigal

-
Scientific Organizers: Melanie M. Ott, Priti Kumar, Olivier Schwartz, and Alex Sigal
Melanie M. Ott
Priti Kumar
Olivier Schwartz
Alex Sigal
***Meeting program subject to change.
Available Formats: = In Person = On DemandMonday, April 8, 2024
Merchandise Options
Registration Options
Booking Function
Tuesday, April 9, 2024
Preparing to Vaccinate Against the Next Pandemic
Principles of Coronaviral Infections
Host-Virus Interactions with Monkeypox Virus
Short Talk: Short Talk: Viral Entry is a Weak Barrier to Zoonosis
Short Talk: Short Talk: Taï Forest Virus: The Virus Sequence Determines the Pathogenic Potential
Short Talk: Short Talk: Bat Organoids: Understanding Emerging Virus Infections through the Lens of Reservoir Species
Research Chair & Professor
Professor of Medicine
Senior Investigator
Associate Director - Infectious Disease Vaccines
How Viral Proteins Shape HIV and SARS-CoV-2 Pathogenesis
Lessons Learned from Flu and SARS-CoV-2
Pathogenicity of Omicron Subvariants
mRNA Therapeutics for SARS-CoV2 and HIV latency
Short Talk: Short Talk: CD81 is a Host Factor for Chikungunya Virus Replication
Wednesday, April 10, 2024
Antibody Responses in People Living with HIV
Entry and Replication of Human Seasonal Coronaviruses and Recent SARS-CoV-2 Variants
Natural Immunity to HIV
Short Talk: Short Talk: Eliciting a Single Amino Acid Change by Vaccination Enables Cross-Group Protective Influenza Antibodies
Short Talk: Short Talk: Evaluating Mechanisms of Protection by Broadly Reactive Anti-Alphavirus Antibodies
Transcriptional Activity of Proviral Sequences as Driver for Clonal Expansion in Chronic HIV Infection
Endocytic Recycling-Dependent Env Antigenic States Affect Neutralization of Cell-Free and Cell-Cell Infection by Broadly Neutralizing Antibodies
Whole Genome Sequencing Reveals Cryptic Circulation of Dengue Virus in the Rainforest Region of Nigeria, West Africa
Functional Antibody Signatures Following Combined Active and Passive Therapeutic Immunization of SHIV-infected Rhesus Macaques
TMPRSS2 is a Functional Receptor for Human Coronavirus HKU1
Spike-Independent Evolution of Recent SARS-CoV-2 Omicron Subvariants Enhances Viral RNA Replication via NSP6 Mutations
Uncovering the Mechanism of Small Molecule Inhibitors Against the RNA Polymerase of SARS-CoV-2
SARS-CoV-2 Evolution and Pathogenesis in PLWH
SARS-CoV-2 Spike Evolution – Balancing Infectivity with Immune Evasion
Evolution of HIV and Other Viruses
Short Talk: Short Talk: SARS-CoV-2 Evolution of Innate Immune Antagonism
Thursday, April 11, 2024
HIV Gene Therapy: A Time to Prevent, a Time to Control, and Now, the Time to Cure
Antibodies Therapeutics in HIV, SARS, Flu, and RSV
Short Talk: Short Talk: Design of Oral Antiviral Drugs for Broad-Spectrum Activity Against Coronaviruses
Short Talk: Short Talk: IL-15/IL-15Ra Cytokine Therapy Leads to Control of Viral Rebound in SIV Infected Macaques
Short Talk: Short Talk: Persistent Reduction of SIV Reservoir Through Short-Term BCL-2 Inhibition at ART Initiation in Rhesus Macaques
Los Alamos National Lab
Los Alamos National Lab
Distinct V2 Apex Broadly Neutralizing Antibody Modalities in Subtype B HIV-1 Infection
The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow Long-Lived Compartment 33 Months after mRNA Vaccination
Anti-Immune Complex Antibodies are Elicited During Repeated Immunization with HIV Env Immunogens
IFNα2 Autoantibodies Post SARS-CoV-2 Wave 1 in India Are Associated with Lower Omicron Symptomology
Transcriptional Profiling of HIV-Specific CD8 T Cell Responses From Lymph Nodes and Blood of Natural Controllers
Immune Signatures Associated with Failure to Seroconvert in Individuals Immunized with MVA-BN as a Vaccine Against MPOX
Evasion of NKG2D-Mediated Cytotoxic Immunity by Sarbecoviruses
A Multivalent mRNA Monkeypox Virus Vaccine (BNT166) Protects Mice and Macaques From Orthopoxvirus Disease
Post-Acute Sequelae of COVID-19
Modeling Post-Acute Sequelae of Ebola Virus Disease
HIV and Chronic Immune Activation: The Impact of Low Nadir CD4 Counts
Short Talk: Short Talk: Lassa Fever is Hallmarked by Inflammation and Kidney Injury or Neurological Disease: Results from the Lassa Fever PATHOGENESIS Study
Friday, April 12, 2024
Fundraising
Subscribe for Updates